Kymera Therapeutics, Inc. SEC filings KYMR
Kymera Therapeutics, Inc. has 647 filings in SEC EDGAR's recent list, going back to Jun 22, 2020. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Oct 29, 2026 | Oct 29, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 27, 2026 | Jul 27, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 25, 2026 | Jun 25, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 24, 2026 | Jun 24, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 8, 2026 | Jun 5, 2026 |
| 8-K |
Current report
Results of operations
|
Apr 30, 2026 | Apr 30, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Mar 27, 2026 | Mar 25, 2026 |
| 8-K |
Current report
Material agreement, Agreement ended, Other events
|
Feb 26, 2026 | Feb 26, 2026 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2026 | Feb 26, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 13, 2026 | Jan 13, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Dec 10, 2025 | Dec 8, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 8, 2025 | Dec 8, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 8, 2025 | Dec 8, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2025 | Nov 4, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 3, 2025 | Aug 27, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2025 | Aug 11, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 27, 2025 | Jun 25, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 27, 2025 | Jun 25, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 25, 2025 | Jun 25, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 25, 2025 | Jun 25, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 2, 2025 | Jun 2, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 2, 2025 | Jun 2, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 9, 2025 | May 9, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 3, 2025 | Mar 3, 2025 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Feb 27, 2025 | Feb 27, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jan 14, 2025 | Jan 14, 2025 |
| 8-K |
Current report
Results of operations
|
Oct 31, 2024 | Oct 31, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Aug 20, 2024 | Aug 19, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2024 | Aug 7, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 8, 2024 | Jul 8, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 20, 2024 | Jun 18, 2024 |
| 8-K |
Current report
Results of operations
|
May 2, 2024 | May 2, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 1, 2024 | Mar 28, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 22, 2024 | Feb 22, 2024 |
| 8-K |
Current report
Material agreement, Results of operations, Other events
|
Jan 5, 2024 | Jan 4, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 4, 2024 | Jan 4, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 4, 2024 | Jan 4, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 2, 2023 | Nov 2, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 2, 2023 | Nov 2, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2023 | Aug 3, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 16, 2023 | Jun 15, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
May 22, 2023 | May 22, 2023 |
| 8-K |
Current report
Results of operations
|
May 4, 2023 | May 4, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 10, 2023 | Mar 10, 2023 |
| 8-K |
Current report
Officer or director change
|
Feb 27, 2023 | Feb 27, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 23, 2023 | Feb 23, 2023 |
| 8-K |
Current report
Results of operations
|
Jan 10, 2023 | Jan 10, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 14, 2022 | Dec 14, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 14, 2022 | Dec 14, 2022 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Nov 3, 2022 | Oct 31, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 13, 2022 | Oct 13, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Aug 19, 2022 | Aug 19, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2022 | Aug 9, 2022 |
| 8-K |
Current report
Officer or director change
|
Jul 8, 2022 | Jul 1, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 16, 2022 | Jun 15, 2022 |
| 8-K |
Current report
Results of operations
|
May 3, 2022 | May 3, 2022 |
| 8-K |
Current report
Officer or director change
|
Apr 11, 2022 | Apr 6, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 24, 2022 | Feb 24, 2022 |
| 8-K |
Current report
Officer or director change
|
Jan 18, 2022 | Jan 17, 2022 |
| 8-K |
Current report
Material agreement, New debt
|
Dec 27, 2021 | Dec 20, 2021 |
| 8-K |
Current report
Other events
|
Dec 16, 2021 | Dec 16, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2021 | Nov 10, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 27, 2021 | Oct 27, 2021 |
| 8-K |
Current report
Officer or director change
|
Sep 16, 2021 | Sep 16, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2021 | Aug 6, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 28, 2021 | Jun 28, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 17, 2021 | Jun 16, 2021 |
| 8-K |
Current report
Results of operations
|
May 6, 2021 | May 6, 2021 |
| 8-K |
Current report
Officer or director change
|
Mar 16, 2021 | Mar 12, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 11, 2021 | Mar 11, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 2, 2021 | Mar 2, 2021 |
| 8-K |
Current report
Results of operations
|
Jan 12, 2021 | Jan 12, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2020 | Nov 5, 2020 |
| 8-K |
Current report
Officer or director change
|
Sep 9, 2020 | Sep 4, 2020 |
| 8-K |
Current report
Material agreement
|
Sep 1, 2020 | Aug 27, 2020 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Aug 25, 2020 | Aug 20, 2020 |
Showing 77 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- KYMR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Watertown, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1815442
- Former names
- Kymera Therapeutics, Inc. (until Oct 29, 2026)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.